Literature DB >> 20702440

Economic evaluation of healthcare safety: which attributes of safety do healthcare professionals consider most important in resource allocation decisions?

L Steuten1, M Buxton.   

Abstract

INTRODUCTION: There is an increasing need to assess the value of safety improvements to society. Concerns exist, however, as to what extent standard health economic methods appropriately reflect this value because these methods do not typically incorporate the non-health or extra-consequentialist value of avoiding healthcare incidents, which may--for example, be associated with a decreased trust of patients and citizens in healthcare systems and providers.
OBJECTIVES: (1) To identify health and non-health attributes of safety from the literature and (2) to prioritise those that are considered most important by healthcare decision-makers and could be included in a subsequent conjoint analysis to determining the relative value of safety interventions and the willingness to pay of decision-makers.
METHODS: A literature review and 25 semistructured interviews have been conducted with healthcare decision-makers experienced in safety management, considering a general healthcare, Methicillin-resistant Staphylococcus aureus (MRSA) and sharps injuries context.
RESULTS: The literature review showed that in addition to likelihood of an incident and its direct medical and cost consequences, factors such as preventability, dread, controllability and trust in safety devices or systems affect the value of safety and decision-makers' willingness to pay. The interview results consistently indicated that "preventability of healthcare incidents", "health consequences", "financial consequences" and "trust in safety systems/devices" are the most important attributes across all contexts. In addition, context-specific attributes were identified.
CONCLUSION: A set of four common and two context-specific attributes, including health and non-health aspects of safety, was identified. The next step is to attaching appropriate levels to these attributes and to incorporate them into a series of case studies among various groups of decision-makers, healthcare professionals, patient groups and the general public.

Entities:  

Mesh:

Year:  2010        PMID: 20702440     DOI: 10.1136/qshc.2008.027870

Source DB:  PubMed          Journal:  Qual Saf Health Care        ISSN: 1475-3898


  7 in total

Review 1.  A review of the methodological challenges in assessing the cost effectiveness of pharmacist interventions.

Authors:  Rachel A Elliott; Koen Putman; James Davies; Lieven Annemans
Journal:  Pharmacoeconomics       Date:  2014-12       Impact factor: 4.981

Review 2.  Devices for preventing percutaneous exposure injuries caused by needles in healthcare personnel.

Authors:  Viraj K Reddy; Marie-Claude Lavoie; Jos H Verbeek; Manisha Pahwa
Journal:  Cochrane Database Syst Rev       Date:  2017-11-14

3.  Evaluation of a predevelopment service delivery intervention: an application to improve clinical handovers.

Authors:  Guiqing Lily Yao; Nicola Novielli; Semira Manaseki-Holland; Yen-Fu Chen; Marcel van der Klink; Paul Barach; Peter J Chilton; Richard J Lilford
Journal:  BMJ Qual Saf       Date:  2012-09-13       Impact factor: 7.035

4.  Process value of care safety: women's willingness to pay for perinatal services.

Authors:  Hisataka Anezaki; Hideki Hashimoto
Journal:  Int J Qual Health Care       Date:  2017-08-01       Impact factor: 2.038

Review 5.  Nurses' experiences in voluntary error reporting: An integrative literature review.

Authors:  Ming Wei Jeffrey Woo; Mark James Avery
Journal:  Int J Nurs Sci       Date:  2021-08-02

6.  Exploring what lies behind public preferences for avoiding health losses caused by lapses in healthcare safety and patient lifestyle choices.

Authors:  Jeshika Singh; Louise Longworth; Amanda Baine; Joanne Lord; Shepley Orr; Martin Buxton
Journal:  BMC Health Serv Res       Date:  2013-07-02       Impact factor: 2.655

7.  Eliciting willingness-to-pay to prevent hospital medication administration errors in the UK: a contingent valuation survey.

Authors:  Sarah R Hill; Nawaraj Bhattarai; Clare L Tolley; Sarah P Slight; Luke Vale
Journal:  BMJ Open       Date:  2022-02-01       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.